Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,219 | 794 | 1,667 | 441 | 2,862 |
| Marketable Securities | 5,484 | 6,178 | 7,483 | 7,293 | 7,790 |
| Other current assets | 430 | 0 | 402 | 841 | 645 |
| TOTAL | $15,134 | $7,394 | $9,552 | $8,575 | $11,296 |
| Non-Current Assets | |||||
| PPE Net | 739 | 785 | 793 | 626 | 524 |
| Other Non-Current Assets | 342 | 349 | 356 | 254 | 254 |
| TOTAL | $1,081 | $1,134 | $1,149 | $880 | $778 |
| Total Assets | $16,214 | $8,528 | $10,701 | $9,455 | $12,074 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,841 | 1,835 | 1,968 | 2,269 | 2,471 |
| TOTAL | $5,454 | $5,705 | $5,667 | $2,269 | $2,471 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,454 | $5,705 | $5,667 | $2,269 | $2,471 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 1 | 1 | 1 | 1 |
| Common Shares | 325 | 224 | 224 | 224 | 224 |
| Retained earnings | -88,382 | -86,028 | -83,127 | -80,651 | -78,055 |
| Other shareholders' equity | 25 | 116 | 125 | 97 | 55 |
| TOTAL | $10,760 | $2,823 | $5,034 | $7,186 | $9,603 |
| Total Liabilities And Equity | $16,214 | $8,528 | $10,701 | $9,455 | $12,074 |